Diabeloop is a medical technology company focused on developing innovative solutions for the management of diabetes. Their flagship product, the DBLG1 System, is an automated solution for the management of Type 1 diabetes.

Diabeloop

WELL Health.ai develops and invests in AI-enabled tools and technologies for healthcare providers, aiming to positively impact health outcomes.

WELL Health.ai

The Diabetes Centre provides comprehensive medical care for diabetes and its related complications. This includes specialized medical services under one roof, catering to a range of diabetes treatment needs.

The Diabetes Centre

We want to provide people living with diabetes with an intelligent therapeutic system to regulate blood glucose. This project was initiated in 2011 by the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) in collaboration with the CEA LETI. After the success of the clinical trials in 2014, we created Diabeloop to bring the project to market and make it available to the largest number of people.Since spring 2021, DBLG1 System, the first automated insulin delivery device, is being marketed in several European countries: Germany, Italy, Spain, Switzerland, the Netherlands and France.

Bpifrance

EASME - EU Executive Agency for SMEs

Crédit Agricole

Sofimac Investment Managers

Air Liquide ALIAD

ODYSSEE VENTURE

KREAXI

Cemag Invest

Sofimac Innovation

Sud Rhone-Alpes Capital

Supernova Invest

Promontoires

Innovacom

LBO France

Terumo Corporation

UI Investissement

Metric
Company Name	Diabeloop	WELL Health.ai	The Diabetes Centre
Symbol
MSH ID	COM:DIABELOOP	AI:WELLHEALTH	ORG:THEDIABETESCENTRE
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare & Health Services	Healthcare Technology	Medical Services
Country	FR	CA	PK
Stage
Employee Count	129
Website	diabeloop.com	wellhealth.ai	thediabetescentre.org
LinkedIn	diabeloop	wellhealthtechnologiescorp	the-diabetes-centre
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:DIABELOOP

Diabeloop

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue